In September 1989, the National Institute on Aging established the nation's first Claude D. Pepper Older Americans Independence Center at the University of Michigan Geriatrics Center. U-M remains one of only 10 NIA-designated Pepper Centers in the country. The overall goals of the U-M Pepper Center are to advance research on health care problems of the elderly and to train future academic leaders in geriatrics. Drawing on the large base of research currently underway in the fields of geriatrics and gerontology at the University of Michigan, the U-M Pepper Center fosters collaborative multidisciplinary research to integrate basic science, clinical science, and health services research relevant to the health care problems of older adults.
The Ann Arbor VA Healthcare System Geriatric Research, Education and Clinical Center is one of 20 national centers of excellence within the Department of Veterans Affairs health care system, designed for the advancement and integration of research, education and clinical achievements in geriatrics and gerontology in the total health care system.
The 3,300 square foot Mobility Research Center houses studies of mobility and physical activity assessment and enhancement in older adults, including mechanisms underlying mobility problems and interventions to address them.
The Paul F. Glenn Center for Aging Research at U-M is part of a consortium of 10 other distinguished research universities whose faculty members are making progress in understanding the biology of aging, and starting to explore ways to translate our growing knowledge about the aging process to benefit people as they grow older. The Center has two components: a Model Systems Unit, that screens chemical compounds to find agents that extend healthy lifespan in worms and flies or that increase resistance of cultured cells to stress, and a Core Facility for Slow-Aging Mice, which produces mice that have been treated with drugs already known to increase lifespan, and then collaborates with expert biologists to learn more about how these drugs work to slow disease and extend lifespan.
The Center to Accelerate Population Research in Alzheimer's (CAPRA) focuses on science that informs government and healthcare organization actions to address the negative impacts of dementia on the health and financial well-being of individuals and the population.